Industry Whitepaper Names Arrive AI's Arrive Point the Model for Solving Medical Drone Delivery's Last-Inch Problem
An AeroX whitepaper positions Arrive AI’s Arrive Point as a reference model for secure, regulated medical drone delivery handoffs.
Rhea-AI Summary
Arrive AI (ARAI)/b) is highlighted in an independent AeroX whitepaper as the structural model for solving the “last‑inch” handoff problem in medical drone delivery in the United States.The paper, titled “Securing the Sky: A Chain of Custody Framework for Medical Drone Delivery in the United States”, maps the complex, multi‑agency regulatory landscape and notes that no single regulator oversees the exact handoff point between parties. It cites Arrive Point’s authenticated access, continuous condition monitoring and documented chain of custody at every transfer as standards the industry should pursue, referencing an Arrive AI deployment at a regional Indiana hospital as a working example. The whitepaper also estimates the global medical drone delivery market could grow from $294 million today to $2.5 billion by 2034.
Positive
- None.
Negative
- None.
Key Figures
- Agencies involved
- At least 7 agencies
- Single U.S. prescription-medication delivery
- Current market size
- $294 million
- Global medical drone delivery market
- 2034 market size
- $2.5 billion
- Global medical drone delivery market forecast
Previous AI Reports
-
Non-binding plan explored drone pharmacy delivery using Arrive Point receiving stations.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
autonomous mobile robots technical
chain of custody regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
INDIANAPOLIS, IN / ACCESS Newswire / September 17, 2026 / Arrive AI (NASDAQ:ARAI), a physical AI and autonomous logistics infrastructure company enabling drones, robots, autonomous mobile robots (AMRs), autonomous vehicles (AVs) and human couriers to securely exchange goods, today highlighted an independent industry whitepaper that names the company's Arrive Point as the model for solving one of the biggest unsolved problems in medical drone delivery: what happens in the final moments of a handoff, when a drone or robot arrives and no one is there to receive the package.
The whitepaper, "Securing the Sky: A Chain of Custody Framework for Medical Drone Delivery in the United States," was published by AeroX, a drone technology and consulting firm. It maps the regulatory landscape around medical drone delivery in the U.S. and finds that at least seven separate federal and state agencies can touch a single delivery of a prescription medication: the FAA governs the aircraft, the FDA governs the drug, the DEA governs controlled substances, and state pharmacy boards govern dispensing. The paper points out that no single agency governs the handoff points between them, the exact moment a package changes hands.
That gap is what Arrive AI's Arrive Point is built to close. The whitepaper cites Arrive Points as a structural model for the industry, pointing to authenticated access, continuous condition monitoring, and a documented chain of custody at every transfer point as the standard other companies in the space should work toward.
The paper points to Arrive AI's deployment at a regional hospital in Indiana, where its technology supports fully asynchronous robotic delivery inside a hospital setting, as a working example of the model in practice.
The whitepaper also points to significant growth ahead for the category. It estimates the global medical drone delivery market at
"Everything gained through fast, convenient and low-cost autonomous delivery and pickup is lost at the front yard of every building and residence in the world. Arrive AI gives autonomy an address," said Dan O'Toole, Founder, Chairman and CEO of Arrive AI.
Arrive AI's platform lets drones, ground robots, autonomous vehicles and human couriers all exchange goods through the same secure, asynchronous delivery point, removing the need for a person to be physically present at the moment of drop-off or pickup.
About Arrive AI
Arrive AI (NASDAQ:ARAI) is building the infrastructure for autonomous logistics through a network of intelligent delivery endpoints that enable secure, asynchronous exchange of goods. The company's platform supports drones, ground robotics, and human couriers, solving the "last inch of the last-mile" challenge across logistics, healthcare, and enterprise delivery.
Forward-Looking Statements
This news release and statements of Arrive AI's management in connection with this release or related events may contain "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events and expected business and financial performance and often include words such as "expects," "anticipates," "intends," "plans," "believes," "potential," "will," "should," "could," "would," "optimistic," or "may," and similar expressions. These statements are based on information available as of the date of this release and reflect management's current views and assumptions. They are not guarantees of future performance and involve known and unknown risks, uncertainties, and other factors that may be beyond the company's control. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this release. Potential investors should review Arrive AI's Registration Statement and other filings, including risk factors, available at the U.S. Securities and Exchange Commission website at www.sec.gov. Arrive AI undertakes no obligation to update forward-looking statements to reflect events or circumstances after the date of this release, except as required by law.
Media Contact
Tasha Jones, Marketing Communications Manager, Arrive AI, media@arriveai.com
Investor Contact
Alliance Advisors IR, ARAI.IR@allianceadvisors.com
SOURCE: Arrive AI, Inc.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who produced the whitepaper that features Arrive AI’s Arrive Point?
The whitepaper, titled “Securing the Sky: A Chain of Custody Framework for Medical Drone Delivery in the United States”, was published by AeroX, a drone technology and consulting firm.
What specific problem in medical drone delivery does Arrive Point address?
Arrive Point is designed to solve the issue of what happens in the final moments of a handoff when a drone or robot arrives and no one is present to receive the package, providing authenticated access, condition monitoring and a documented chain of custody at that transfer point.
How is Arrive AI’s technology currently being used in healthcare?
The whitepaper cites a deployment at a regional hospital in Indiana where Arrive AI’s technology supports fully asynchronous robotic delivery inside the hospital setting.
What market growth does the whitepaper project for medical drone delivery?
The whitepaper estimates the global medical drone delivery market at $294 million today and projects it could reach $2.5 billion by 2034 as more health systems adopt drone delivery for time‑sensitive items such as lab samples, medications and blood products.
What types of delivery modes does Arrive AI’s platform support?
Arrive AI’s platform enables secure, asynchronous exchange of goods by drones, ground robots, autonomous vehicles and human couriers through the same delivery endpoints.